Chesapeake IRB Completes Acquisition of IRB Services
Adds largest independent and only AAHRPP-accredited Canadian IRB/REB to the Chesapeake IRB organization
Chesapeake IRB, headquartered in Columbia, Maryland announced it has completed the acquisition of IRB Services, headquartered in Aurora, Ontario, Canada.
IRB Services and Chesapeake IRB are providers of federally mandated institutional review board (“IRB”) services to pharmaceutical, biotech and medical device companies, universities, academic medical centers, hospital systems, governmental entities and others required to use IRB services to assure the protection of rights and the welfare of human subjects participating in research.
Jeff Wendel, President of Chesapeake IRB, said, “Adding IRB Services to our team is the realization of a long time goal for us, because it offers our clients a combined North American expertise and service capability that is unparalleled in our industry. IRB Services’ outstanding reputation and long standing dedication to the protection of human subjects participating in research across Canada enhances Chesapeake IRB’s services and capabilities.”
IRB Services, the largest independent and only AAHRPP-accredited Canadian IRB/REB, founded in 1993, will retain its name, leadership, and Canadian location, operating as a wholly-owned subsidiary of Chesapeake IRB.
The combination of two highly regarded, AAHRPP accredited organizations will efficiently deliver a unique solution to organizations conducting research in Canada and the US.
Jack Corman, Founder and CEO of IRB Services, said, “We are delighted to be able to come together with a like-minded organization; one that places the highest emphasis on integrity and quality in its service offering. In addition, we are looking forward to leveraging the CIRBI electronic submission platform to create a truly superlative IRB offering to our clients.”
Elyse Summers, President and CEO, Association for the Accreditation of Human Research Protection Programs, commented, “AAHRPP is delighted to see that its internationally recognized accreditation standards can become a cornerstone of commonality for two highly regarded, quality-driven IRBs. AAHRPP recognizes the important role it plays assuring that the review of clinical research takes place through accredited organizations that adhere to the highest level of safety and quality globally.”
For questions regarding Chesapeake IRB or IRB Services please contact:
Jeffrey Wendel – President, Chesapeake IRB (410) 884-2900
Jack Corman – Managing Director, IRB Services (905) 727- 7989
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
